https://webnewsinsider.com/why-achieve-says-most-americans-feel-their-financial-stability-is-slipping-away/ WebNewsInsider en 2026-11-10T23:25:04+08:00 Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away https://webnewsinsider.com/locking-in-high-yields-how-current-cd-rates-offer-safe-returns-amid-shifting-economic-outlooks/ WebNewsInsider en 2026-11-10T23:23:17+08:00 Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks https://webnewsinsider.com/factor-xia-inhibitor-asundexian-cuts-recurrent-stroke-risk-without-raising-major-bleeding/ WebNewsInsider en 2026-11-10T09:11:30+08:00 Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding https://webnewsinsider.com/ucsf-scientists-eliminate-deadly-brain-tumors-in-mice-with-b-sync-therapy/ WebNewsInsider en 2026-11-10T07:21:34+08:00 UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy https://webnewsinsider.com/medicare-denies-949-multi-cancer-blood-test-leaving-seniors-with-full-bill-until-2029/ WebNewsInsider en 2026-11-10T06:21:03+08:00 Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029 https://webnewsinsider.com/indias-nppa-slashes-137-cancer-drug-prices-by-up-to-96-saving-%e2%82%b93500-crore-annually/ WebNewsInsider en 2026-11-10T02:14:35+08:00 India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually https://webnewsinsider.com/fda-orders-class-wide-glp-1-label-update-for-rare-eye-disease-risk/ WebNewsInsider en 2026-11-10T00:21:16+08:00 FDA orders class-wide GLP-1 label update for rare eye disease risk https://webnewsinsider.com/why-oncology-trials-chase-surrogate-endpoints-the-fda-ignores/ WebNewsInsider en 2026-11-09T23:22:29+08:00 Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores https://webnewsinsider.com/understanding-metastatic-prostate-cancer-prognosis-and-modern-treatment-pathways/ WebNewsInsider en 2026-11-09T09:11:34+08:00 Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways https://webnewsinsider.com/inside-abbvies-high-stakes-neuro-portfolio-and-pipeline-strategy/ WebNewsInsider en 2026-11-09T08:13:34+08:00 Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy https://webnewsinsider.com/nangibotide-targets-acute-on-chronic-liver-failure-with-phase-2-data-due-2027/ WebNewsInsider en 2026-11-09T08:11:53+08:00 Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027 https://webnewsinsider.com/how-ueno-banks-collapse-toppled-paraguays-president-and-shook-financial-trust/ WebNewsInsider en 2026-11-09T07:11:50+08:00 How Ueno Bank’s Collapse Toppled Paraguay’s President and Shook Financial Trust https://webnewsinsider.com/why-insurers-send-their-own-nurses-to-deny-long-term-care-claims/ WebNewsInsider en 2026-11-09T01:23:07+08:00 Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims https://webnewsinsider.com/us-i-bonds-hit-5-51-rate-highest-fixed-component-in-two-decades/ WebNewsInsider en 2026-11-09T00:20:55+08:00 US I-Bonds Hit 5.51% Rate, Highest Fixed Component in Two Decades